Article
OUP accepted manuscript
1 Jan 2019
Abstract excerpt
BACKGROUND: Artemisinin-based combination therapy (ACT) is the global standard of care for uncomplicated falciparum malaria. First reports of ACT resistance came from western Cambodia and the Thailand-Cambodia border in 2002-2004. The subsequent emergence and expansion of Plasmodium falciparum strains resistant to the artemisinin component and ACT are now threatening the efficacy of falciparum malaria treatment....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
